drugset / Trial / NCT00927654

Iloprost in High Risk Cardiac Surgical Patients

NCT00927654

RandomizedParallel-groupTriple-blindTreatment

Summary

In this study effects of the intra operative, prophylactic inhalation of Iloprost (Ventavis) before and during extracorporal circulation on perioperative morbidity and outcome in high risk cardiac surgical patients is investigated in comparison to placebo.

Timeline

Start
2009-06
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Iloprost Other / unclassified 20 ug Inhaled